Lorenzl et al. (2003b) demonstrated that plasma concentrations of MMP-9 in ALS patients were not statistically different from controls, while TIMP-1 and TIMP-2 levels were unchanged. This evidence concerns the gene MMP9 and amyotrophic lateral sclerosis.